← Back to Clinical Trials
Recruiting NCT03988764

NCT03988764 Monogenic Diabetes Misdiagnosed as Type 1

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03988764
Status Recruiting
Phase
Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Condition Diabetes Mellitus, Type 1
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2019-09-24
Primary Completion 2025-12-31

Trial Parameters

Condition Diabetes Mellitus, Type 1
Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age 1 Day
Max Age 25 Years
Start Date 2019-09-24
Completion 2025-12-31
Interventions
None AHT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type. Exclusion Criteria: * Existing T1D autoantibody testing with a positive result

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology